Home / Resource Library / Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphoma

Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphoma

Study examined outcomes of patients with MCL treated with ibrutinib prior to CAR-T therapy.